458 results on '"Murphy, Robert C"'
Search Results
2. Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples
3. Overview of Lipid Mass Spectrometry and Lipidomics
4. Lipids and Inflammation
5. Data from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
6. Data from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
7. Supplementary Table S3 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
8. Supplementary Table S2 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
9. Supplementary Figure S1 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
10. Supplementary Table S2 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
11. Supplementary Figure S1 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
12. Supplementary Table S1 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
13. Supplementary Table S3 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
14. Supplementary Table S1 from Biomarkers for Personalizing Omega-3 Fatty Acid Dosing
15. Supplemental Figures S1-S6 from Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor
16. Data from Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor
17. Data from Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor
18. Supplementary Methods from Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor
19. Table Supplementary S-I from Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor
20. The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses
21. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
22. Contributors
23. The Eicosanoids
24. The SARS-CoV2 envelope is distinct from host membranes, exposes pro-coagulant lipids, and can be inactivated in vivo by surfactant-containing oral rinses.
25. Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation
26. Imaging Lipids in Tissues by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry
27. Lipidomic and transcriptional analysis of the linoleoyl-omega-hydroxyceramide biosynthetic pathway in human psoriatic lesions
28. The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways
29. List of contributors**Authors’ names are followed by the starting page number(s) of their contribution(s).
30. Steps Toward Minimal Reporting Standards for Lipidomics Mass Spectrometry in Biomedical Research Publications
31. Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures
32. Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation
33. An improved and highly selective fluorescence assay for measuring phosphatidylserine decarboxylase activity
34. Lipid mass spectrometry: A path traveled for 50 years
35. Lipid mass spectrometry: A path traveled for 50 years
36. Neutral Lipidomics and Mass Spectrometry
37. Qualitative Analysis and Quantitative Assessment of Changes in Neutral Glycerol Lipid Molecular Species Within Cells
38. Prostaglandins and Leukotrienes
39. Covalent Binding of Leukotriene A4 to Nucleosides, Nucleotides, and Nucleic Acids
40. IL-4-Induced Lipid Mediators Class Switching in Human Normal Mononuclear Phagocytes
41. Chapter 13 The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways
42. Electrospray Mass Spectrometric Analysis of Lipid Mediators Derived from Arachidonic Containing Membrane Phospholipids
43. Metabolism of leukotrienes and formation of new leukotriene structures
44. Oxidation of Arachidonate Containing Glycerophospholipids in Intact Red Blood Cells and Red Blood Cell Membranes with Tert-Butylhydroperoxide
45. Mass Spectrometry of Isoeicosanoids as Novel Lipid Substances
46. Free Radical-Induced Oxidation of Glycerophosphocholine Lipids and Formation of Biologically Active Products
47. Metabolism of Eicosanoids in Mammalian Cells
48. Isoeicosanoids: Mass Spectrometry of Free Radical Oxidation Products Derived From Arachidonoyl Phospholipids
49. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection
50. Revising the structure of a new eicosanoid from human platelets to 8,9–11,12-diepoxy-13-hydroxyeicosadienoic acid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.